4.6 Article

Cost-effectiveness of radioguided occult lesion localization using 125I seeds versus hookwire localization before breast-conserving surgery for non-palpable breast cancer

Journal

BRITISH JOURNAL OF SURGERY
Volume 108, Issue 7, Pages 843-850

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bjs/znaa160

Keywords

-

Categories

Funding

  1. Ladybird Foundation
  2. Western Australian Health Translation Network Early Career Fellowship
  3. Australian Government's Medical Research Future Fund as part of the Rapid Applied Research Translation program
  4. National Breast Cancer Foundation Investigator Initiated Research Scheme [IIRS-20-011]

Ask authors/readers for more resources

The study found that radioguided occult lesion localization using I-125 seeds is likely to be cost-effective compared to hookwire localization, with an incremental cost-effectiveness ratio of $4474 per reoperation avoided. Uncertainty around the probability of reoperation was identified as a key factor influencing the cost-effectiveness of using I-125 seeds for localization.
Background: The aim was to determine the cost-effectiveness of radioguided occult lesion localization using I-125-labelled seeds (I-125 seeds) versus hookwire localization in terms of incremental cost per reoperation avoided for women with non-palpable breast cancer undergoing breast-conserving surgery. Methods: This study was based on a multicentre RCT with eight study sites comprising seven public hospitals and one private hospital. An Australian public health system perspective was taken. The primary effectiveness outcome for this study was reoperations avoided. Cost-effectiveness was expressed as an incremental cost-effectiveness ratio (ICER). One-way and probabilistic sensitivity analyses were used to explore uncertainty. The willingness to pay (additional cost of localization using I-125 seeds justified by reoperation cost avoided) was set at the weighted, top-down cost of reoperation. Costs were in 2019 Australian dollars ($1 was equivalent to Euro0.62). Results: The reoperation rate was 13.9 (95 per cent confidence interval 10.7 to 18.0) per cent for the I-125 seed group and 18.9 (14.8 to 23.8) per cent for the hookwire localization group. The ICER for I-125 seed versus hookwire localization was $4474 per reoperation averted. The results were most sensitive to uncertainty around the probability of reoperation. Accounting for transition probability and cost uncertainty for I-125 seed localization, there was a 77 per cent probability that using I-125 seeds would be cost-effective, with a willingness to pay of $7693 per reoperation averted. Conclusion: Radioguided occult lesion localization using I-125 seeds is likely to be cost-effective, because the marginal (additional) cost compared with hookwire localization is less than the cost of reoperations avoided.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available